Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Colorcon
AstraZeneca
Medtronic
McKinsey

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR BACLOFEN


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Baclofen

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000303 ↗ Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6 Completed National Institute on Drug Abuse (NIDA) Phase 2 1997-10-01 The purpose of this study is to empirically test a series of medications to: 1) determine each medication's efficacy in treatment of cocaine abuse/dependence; 2) find most effective dose range for each medication. In this study, baclofen is tested.
NCT00000303 ↗ Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6 Completed University of California, Los Angeles Phase 2 1997-10-01 The purpose of this study is to empirically test a series of medications to: 1) determine each medication's efficacy in treatment of cocaine abuse/dependence; 2) find most effective dose range for each medication. In this study, baclofen is tested.
NCT00004431 ↗ Randomized Study of L-Baclofen in Patients With Refractory Trigeminal Neuralgia Completed University of Pittsburgh N/A 1998-06-01 OBJECTIVES: I. Evaluate the efficacy of L-baclofen in patients with refractory trigeminal neuralgia. II. Evaluate the safety and tolerance of L-baclofen in these patients.
NCT00082485 ↗ Baclofen for the Treatment of Cocaine Dependence - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 2004-06-01 The purpose of this study is to assess the efficacy and safety of baclofen for the treatment of cocaine dependence.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Baclofen

Condition Name

Condition Name for Baclofen
Intervention Trials
Alcohol Dependence 9
Spasticity 7
Cerebral Palsy 6
Alcoholism 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Baclofen
Intervention Trials
Alcoholism 18
Muscle Spasticity 13
Cerebral Palsy 8
Disease 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Baclofen

Trials by Country

Trials by Country for Baclofen
Location Trials
United States 196
France 12
Canada 11
United Kingdom 9
Belgium 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Baclofen
Location Trials
New York 14
Texas 13
California 12
Minnesota 10
Pennsylvania 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Baclofen

Clinical Trial Phase

Clinical Trial Phase for Baclofen
Clinical Trial Phase Trials
Phase 4 26
Phase 3 14
Phase 2/Phase 3 8
[disabled in preview] 28
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Baclofen
Clinical Trial Phase Trials
Completed 69
Terminated 16
Recruiting 8
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Baclofen

Sponsor Name

Sponsor Name for Baclofen
Sponsor Trials
National Institute on Drug Abuse (NIDA) 6
VA Office of Research and Development 4
Medtronic 4
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Baclofen
Sponsor Trials
Other 125
Industry 36
NIH 14
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Dow
Colorcon
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.